Table 6.
12-month, 60-month and 120-month relative survival rates of melanoma patients according to sex, age group, and calendar period from 1974 to 2013 at eighteen SEER sites. Data are means ± standard error of the mean, with number of patients in parentheses
| Decade | Age Group | Sex | |
|---|---|---|---|
|
| |||
| Male | Female | ||
| 74-83 | 12-Mo RS | ||
| All | 92.80±0.30 (8198) | 96.00±0.30 (8263)*** | |
| 0-39 | 96.8±0.30 (2704) | 94.9±0.50 (2791) | |
| 40-54 | 93.8±0.50 (2316) | 97.50±0.40 (2214)*** | |
| 55-69 | 92.30±0.60 (2553) | 94.80±0.60 (1901)** | |
| 70-84 | 89.3±1.20 (1107) | 90.5±1.10 (1073) | |
| 85+ | 84.00±4.60 (148) | 90.30±2.90 (284) | |
| 60-Mo RS | |||
| All | 77.30±0.60 | 85.8±0.50*** | |
| 0-39 | 86.90±0.50 | 80.40±0.90*** | |
| 40-54 | 79.50±0.90 | 88.30±0.70*** | |
| 55-69 | 77.3±1.0 | 83.4±1.0*** | |
| 70-84 | 68.80±2.20 | 72.80±1.90 | |
| 85+ | 48.70±9.20 | 66.1±5.1 | |
| 120-Mo RS | |||
| All | 71.9±0.7 | 81.6±0.60*** | |
| 0-39 | 75.10±1.00 | 88.50±0.60*** | |
| 40-54 | 74.5±1.1 | 84.00±0.90*** | |
| 55-69 | 71.2±1.30 | 78.4±1.3*** | |
| 70-84 | 60.8±2.9 | 66.2±2.7 | |
| 85+ | 36.8±16.7 | 55.3±10.7 | |
| 84-93 | 12-Mo RS | ||
| All | 95.50±0.20 (15002) | 97.20±0.20 (13408)*** | |
| 0-39 | 96.30±0.30 (3124) | 98.9±0.2 (4309)*** | |
| 40-54 | 96.50±0.30 (4114) | 97.70±0.30 (3549)** | |
| 55-69 | 94.90±0.40 (4733) | 97.30±0.40 (2958)*** | |
| 70-84 | 94.70±0.60 (2669) | 94.60±0.70 (2074) | |
| 85* | 90.5±2.70 (362) | 89.10±2.10 (518) | |
| 60-Mo RS | |||
| All | 85.10±0.40 | 90.50±0.30*** | |
| 0-39 | 86.80±0.60 | 94.6±0.4*** | |
| 40-54 | 86.20±0.60 | 92.30±0.50*** | |
| 55-69 | 85.1±0.7 | 89.80±0.70*** | |
| 70-84 | 82.60±1.40 | 83.00±1.30 | |
| 85+ | 68.8±5.9 | 72.3±4.1 | |
| 120-Mo RS | |||
| All | 81.90±0.50 | 88.20±0.40*** | |
| 0-39 | 83.00±0.70 | 92.50±0.40*** | |
| 40-54 | 82.00±0.70 | 89.10±0.60*** | |
| 55-69 | 83.5±0.9 | 87.9±0.9** | |
| 70-84 | 79.5±1.4 | 79.2±1.9 | |
| 85+ | 38.4±10.3 | 72.3±4.1*** | |
| 94-03 | 12-Mo RS | ||
| All | 96.40±0.10 (41349) | 97.60±0.10 (34004)*** | |
| 0-39 | 97.60±0.20 (5629) | 99.00±0.10 (8467)*** | |
| 40-54 | 96.70±0.20 (12223) | 98.30±0.10 (10653)*** | |
| 55-69 | 96.60±0.20 (12738) | 96.90±0.20 (7462) | |
| 70-84 | 95.40±0.30 (9324) | 95.90±0.40 (5924) | |
| 85+ | 96.50±0.10 (1435) | 97.70±0.10 (1468)*** | |
| 60-Mo RS | |||
| All | 88.10±0.20 | 92.50±0.20*** | |
| 0-39 | 90.7±0.40 | 96.50±0.20*** | |
| 40-54 | 89.00±0.30 | 94.10±0.30*** | |
| 55-69 | 88.90±0.40 | 91.80±0.40*** | |
| 70-84 | 85.80±0.70 | 87.30±0.80 | |
| 85+ | 89.40±0.20 | 93.20±0.20*** | |
| 120-Mo RS | |||
| All | 85.70±0.30 | 90.60±0.30*** | |
| 0-39 | 87.8±0.5 | 95.20±0.30*** | |
| 40-54 | 86.20±0.40 | 92.10±0.30*** | |
| 55-69 | 87.2±0.5 | 89.4±0.5** | |
| 70-84 | 82.80±1.10 | 85.8±1.1 | |
| 85+ | 70.70±4.60 | 66.30±5.90 | |
| 04-13 | 12-Mo RS | ||
| All | 96.50±0.10 (77685) | 97.70±0.10 (61332)*** | |
| 0-39 | 97.50±0.20 (7095) | 99.20±0.10 (11799)*** | |
| 40-54 | 96.60±0.10 (18837) | 98.60±0.10 (18229)*** | |
| 55-69 | 96.40±0.10 (28831) | 97.60±0.10 (17095)*** | |
| 70-84 | 96.50±0.20 (18996) | 96.30±0.30 (11027) | |
| 85+ | 95.10±0.80 (3926) | 91.60±0.80 (3182)** | |
| 60-Mo RS | |||
| All | 89.40±0.20 | 93.20±0.20*** | |
| 0-39 | 91.80±0.40 | 96.90±0.20*** | |
| 40-54 | 90.30±0.30 | 95.30±0.20*** | |
| 55-69 | 89.50±0.30 | 93.20±0.30*** | |
| 70-84 | 87.70±0.60 | 88.60±0.60 | |
| 85+ | 83.40±2.50 | 77.70±2.40 | |
| 120-Mo RS | |||
| All | 84.90±0.40 | 90.80±0.37*** | |
| 0-39 | 88.10±0.59 | 95.15±0.35*** | |
| 40-54 | 86.40±0.52 | 93.40±0.35*** | |
| 55-69 | 87.80±0.54 | 91.60±0.56*** | |
| 70-84 | 83.00±1.30 | 87.80±0.76** | |
| 85+ | 73.00±8.20 | 62.00±7.50 | |
Abbreviations: Mo, month; RS, relative survival; SEM, standard error of the mean.
*
P < 0.01;
**
P < 0.001;
***
P < 0.0001.